Articles

OFIX stock results show that Orthofix Medical met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. More

QURE stock results show that uniQure missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. More

CGTX stock results show that Cognition Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. More

RPHM stock results show that Reneo Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024. More

Capitalize on these three undervalued Cathie Wood stocks, harnessing long-term gains from amid market fluctuations. More

MLTX stock results show that MoonLake missed analyst estimates for earnings per share the first quarter of 2024. More

NVCT stock results show that Nuvectis Pharma beat analyst estimates for earnings per share the first quarter of 2024. More

Subscriber Sign in